and changed its name to Aspira Women's Health Inc. The company was formerly known as Vermillion, Inc. It serves physician office and hospital laboratories, as well as physicians. eToro Best UK Stock Broker Overall Best UK Stock Broker for Low Fees Libertex Best Stock CFD Broker Fineco Bank Buy and Sell Shares in the UK from £2. The company has a strategic alliance with Quest Diagnostics, Incorporated. The latest ASX small and microcap health news covering everything from drug and biotech developments to medical devices and medicinal cannabis.The latest news about ASX-listed small and micro cap. If you don’t have time to read our guide in full, here’s a list of our best UK stock brokers.
It has entered into a collaborative research agreement with Baylor Genetics to co-develop a novel ovarian cancer early-detection test and an agreement with Dana Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer. Further, the company is developing diagnostic algorithms and a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer.
In addition, it owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. It provides OVA1, Overa, and Ova1PLUS to detect the risk of ovarian malignancy. Healthcare | Diagnostics & Research | USAĪspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States.
0 kommentar(er)
